Side Effects of Q-Switched Ruby Laser for the Treatment of Lentigines in Light and Dark Skin Types

The purpose of this study is a comparison of efficacy and side effects of Q-switched Ruby laser treatment for solar lentigines in two different skin types II and IV.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Solar Lentigines

Age range

Up to 80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

Skin Research Center, Shohada-e Tajrish Hospital, Shaheed Beheshti Medical University

Tehran, Tehran Province, 19899, Iran

About this study

It has been widely accepted that dark colored individuals are prone to develop laser induced side effects especially post inflammatory hyperpigmentation(PIH) and it could be a limiting issue in selecting dark colored individuals.

We designed this study to evaluate the difference of efficacy and side effects in light and dark skinned individuals.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Solar Lentigines
Fitzpatrick skin type II and IV

Exclusion criteria

Pregnancy
Age above 80
Photosensitivity
Concern for malignancy
Active Infection

Treatment and study plan

Q-switched Ruby Laser

Device

Primary outcomes

Clinical Clearance
Side Effects

Sponsors and collaborators

Lead sponsor

Shahid Beheshti University of Medical Sciences

Other

Registry information

Official study title

Efficacy and Side Effects of Q-Switched Ruby Laser Treatment of Solar Lentigines in Two Different Fitzpatrick Skin Types II and IV

Important dates

Study start: 2005
Study completion: 2006
First posted: Oct 11, 2006
Registry last updated: Jun 4, 2008

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed